ArticleClinical epigenetics2026

HRR gene promoter methylation-guided nomogram predicts PARP inhibitor efficacy and progression-free survival in high-grade serous ovarian cancer.

Zhihua Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.